Live tape
Top 8, mentions 7d10,913GOOGL2,081 mentions▲ +0.04SNDK1,536 mentions▲ +0.11SPCX1,501 mentions▲ +0.08NBIS1,429 mentions▲ +0.10HTZ1,239 mentions▲ +0.10NVDA1,212 mentions▲ +0.08META1,065 mentions▲ +0.03MSFT850 mentions▲ +0.06

Equity · Healthcare

TECH

Bio-Techne Corporation · NasdaqGS

$72.30 +0.41% 1D Finazon · prior-day close · Aug 7, 2026
Price · Chart
Our own end-of-day closes 55 sessions
$80 $40 20 May 7 Aug

The line runs $46.70 on 20 May through $72.30 on 7 August, on a scale from $40 to $80. Days the market did not trade hold the previous close, flat.

The chart above plots the price of TECH over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 55 sessions over that window: $46.70 on 20 May 2026 through $72.30 on 7 August 2026.

Market cap $11.3B
P/E (TTM) 76.9
52-week range $43.30 – $72.30
Avg volume 1.1M

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

TECH insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 29 Jul 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 8

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
29 Jul 2026 Hippel James CFO Option exercise 62,068 $2.95M
29 Jul 2026 Hippel James CFO Tax withheld 51,024 $3.68M
28 Jul 2026 Kelderman Kim Chief Executive Officer Option exercise 35,000 $1.67M
28 Jul 2026 Kelderman Kim Chief Executive Officer Tax withheld 28,686 $2.07M
23 Jul 2026 Bohnen Shane SVP - General Counsel Option exercise 448 $21K
23 Jul 2026 Bohnen Shane SVP - General Counsel Tax withheld 344 $25K
02 Jun 2026 Crouse Steven C. President - Diag & Spatial Bi Option exercise 600
02 Jun 2026 Crouse Steven C. President - Diag & Spatial Bi Tax withheld 216 $11K

TECH reported financials

SEC EDGAR XBRL

TECH reported revenue of $1.2B for the fiscal year ended 30 Jun 2025. Net income over the same period was $73.4M.

Figure Reported Period
Revenue $1.2B 30 Jun 2025 fiscal year
Net income $73.4M 30 Jun 2025 fiscal year
Diluted EPS $0.46 30 Jun 2025 fiscal year
Total assets $2.6B 31 Mar 2026 at period end
Total equity $2.1B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

TECH earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q3 2026 $0.32 $311M
31 Dec 2025 Q2 2026 $0.24 $296M
30 Sep 2025 Q1 2026 $0.24 $287M
30 Jun 2025 FY 2025 $0.46 $1.22B
31 Mar 2025 Q3 2025 $0.14 $316M
31 Dec 2024 Q2 2025 $0.22 $297M
30 Sep 2024 Q1 2025 $0.21 $289M
30 Jun 2024 FY 2024 $1.05 $1.16B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

TECH institutional holders

SEC Form 13F

14 of the 45 institutional funds we track reported a TECH position for the quarter ended 30 Jun 2026 — a combined $471.2M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Maverick Capital Trimmed −67.6% shares 1,535,610 $108.5M
Millennium Management New position 989,033 $69.9M
Citadel Advisors Added +2,125.5% shares 965,918 $68.2M
Tudor Investment Corp New position 943,287 $66.6M
Balyasny Asset Management New position 836,870 $59.1M
Soros Fund Management New position 535,400 $37.8M
Man Group Added +5,404.6% shares 360,000 $25.4M
D. E. Shaw & Co. New position 228,479 $16.1M
Marshall Wace Held (±25%) −4.1% shares 89,484 $6.3M
Two Sigma Investments Held (±25%) +5.3% shares 69,625 $4.9M

Showing the 10 largest of 14 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings

TECH fails-to-deliver

SEC CNS data

On 22 Jul 2026, 98 shares of TECH failed to deliver (about $7K).

Settlement date Shares failed Notional % of shares out
22 Jul 2026 98 $7K <0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in TECH

STOCK Act disclosures

The most recent congressional trade disclosed in TECH is a purchase by April McClain Delaney (house, MD), dated 05 Dec 2025.

Date Member Type Amount
05 Dec 2025 filed 05 Jan 2026 April McClain Delaney house · Democrat–MD Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures